跳至主要内容
临床试验/NCT06330610
NCT06330610招募中不适用

Evaluation de l'efficacité du Support Nutritionnel entéral Intermittent Sur la défaillance d'Organes de Patients de réanimation Sous Ventilation assistée ENteral NUTrition - Continue Intermittent

University Hospital, Rouen2 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2024年7月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
174
试验地点
2
主要终点
Evolution of variation of the SOFA (Sepsis-related organ failure assessment) score.

研究概览

简要总结

This study aims to evaluate the efficiency of intermittent enteral nutrition versus continuous enteral nutrition to prevent from organ failures for patients at the acute phase of sepsis shock with mechanical ventilation in ICU.

详细描述

Some pre-clinical and observational studies have suggested that intermittent fasting may have a positive impact on patients in ICU by increasing protein synthesis, sensibility to insulin, cetogenesis, autophagy by respecting the circadian rhythm. This study aims to evaluate the impact on organ failures of an intermittent enteral nutrition versus continuous enteral nutrition in patients at the acute phase of sepsis shock with mechanical ventilation in the ICU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient admitted in ICU for less than 48h, with invasive mechanical ventilation predicted for at least 48h, that can undergo nasogastric feeding for 7 days.
  • Patient under vasopressive drugs
  • Adult patients (age ≥ 18 years)
  • Informed person who has read and signed their consent
  • If the patient is unable to sign their consent (emergency situation), the consent will be signed by a trusted person or a family member, and consent to continue the study will be requested subsequently.
  • If the patient is unable to sign their consent (emergency situation) and no trusted person is present, the patient may be included in the study. In this case, consent to continue the study will be requested from a trusted person as soon as possible, or from the patient if they are able to understand and sign the consent.
  • Affiliation to a social security scheme
  • No current pregnancy: for women of childbearing age, a beta-HCG blood pregnancy test will be performed upon inclusion; for postmenopausal women, a confirmatory diagnosis must be obtained.

排除标准

  • Contraindication to enteral nutrition and/or nasogastric tube insertion: esophageal varices and occlusive syndrome
  • Artificial enteral nutrition that cannot be initiated within 48 hours of intubation
  • Enteral nutrition ongoing for more than one hour at the time of inclusion
  • Need for exclusive or supplemental parenteral nutrition
  • Moribund patient
  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
  • Pregnant or breastfeeding woman

研究组 & 干预措施

continuous enteral nutrition

No Intervention

patients that receive continuous enteral nutrition

Intermittent enteral nutrition

Experimental

patients that receive intermittent enteral nutrition.

干预措施: Intermittent enteral nutrition (Other)

结局指标

主要结局

Evolution of variation of the SOFA (Sepsis-related organ failure assessment) score.

时间窗: day-1 (nutrition start) and day-7

Comparison of variation of the SOFA score between patients with intermittent nutrition versus patients with continuous nutrition.

次要结局

  • Evaluation of death(from day 1 to day 90)
  • evaluation of caloric intake(from day-1 (nutrition start) to day-7)
  • evaluation of protein intake(from day-1 (nutrition start) to day-7)
  • Measurement of nutritionnal status(day-1 (nutrition start) and day-7)
  • Evaluation of the digestive tolerance(from day-1 (nutrition start) to day-7)
  • Evaluation of the metabolic response(day 1, day 4 and day 7)
  • Evaluation of quality of life(up to day 90)
  • Evaluation of the nosocomial infections(from day-1 (nutrition start) to day-7)
  • Adverse events(from day-1 (nutrition start) to day-7)
  • Evaluation of the duration of hospitalisation(day 1 to day 90)
  • Evaluation of the intensive care neuromuscular weakness(Up to day 10)

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验